Supernus Pharmaceuticals
SUPN
#4297
Rank
C$2.81 B
Marketcap
$50.94
Share price
0.55%
Change (1 day)
38.50%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): $1.07

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $1.10. In 2022 the company made an earnings per share (EPS) of $1.57 an increase over its 2021 EPS that were of $1.42.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.07-31.87%
2022$1.5710.78%
2021$1.42-57.68%
2020$3.3512.09%
2019$2.990.47%
2018$2.9889.38%
2017$1.57-38.59%
2016$2.56534.48%
2015$0.40-211.54%
2014-$0.36-91.1%
2013-$4.0639.46%
2012-$2.91-69.27%
2011-$9.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$26.89 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.56 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.53 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.14 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.60 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA